The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy. - Wikidata - awgldk - TriplyDB

The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy.

The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy.

http://www.wikidata.org/entity/Q35060404

about

Protein transduction therapy into cochleae via the round window niche in guinea pigs.Modulation of K(Ca)3.1 channels by eicosanoids, omega-3 fatty acids, and molecular determinants Structural Insights into the Atomistic Mechanisms of Action of Small Molecule Inhibitors Targeting the KCa3.1 Channel Pore.Ion channels in innate and adaptive immunity Potassium Channels in Regulation of Vascular Smooth Muscle Contraction and Growth.KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma.NMDA-receptor antagonists block B-cell function but foster IL-10 production in BCR/CD40-activated B cells The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke.Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke.

P2860

Q30375640-814FF548-7BC3-419F-9788-4B54EFAD0A17 Q35395940-00D81DF5-B7E0-4006-8F79-F0BEA4D6324D Q36261948-5B23A209-E818-4099-A3C8-CDC685C36EC8 Q36769825-4909F035-5D11-4DE8-AFA5-56831D844D25 Q39141080-0ADAEC1F-F049-419B-8987-DE5172C0F048 Q39413648-D47907C4-D621-44A6-A7F7-2E14AE9143CC Q41616016-218CAF5B-4DFD-4382-844C-FC4DF723A515 Q46017939-DF4E766F-CDAD-4C16-B2F8-C23DCC2A7384 Q55087612-5419943E-09CD-4618-9F0F-9EE94D68B23C

P2860

The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy.

http://www.wikidata.org/entity/Q35060404

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

The Ca²⁺-activated K⁺ channel ...... ion of allograft vasculopathy.

@ast

The Ca²⁺-activated K⁺ channel ...... ion of allograft vasculopathy.

@en

type

label

The Ca²⁺-activated K⁺ channel ...... ion of allograft vasculopathy.

@ast

The Ca²⁺-activated K⁺ channel ...... ion of allograft vasculopathy.

@en

prefLabel

The Ca²⁺-activated K⁺ channel ...... ion of allograft vasculopathy.

@ast

The Ca²⁺-activated K⁺ channel ...... ion of allograft vasculopathy.

@en

P1433

Q35060404-0D0033CC-4DCB-492E-9624-851FDA1FAF91

P1476

Q35060404-BD4EC4EC-5982-41DB-BF8A-7B59CB967C98

P2093

Q35060404-1C5AC9F8-E1A8-4EBF-91F7-9A6AF9151B4D

Q35060404-2F76E8DF-1E0C-4FA1-AB10-9FA29692C7A5

Q35060404-5ACB6D3E-2D33-4570-9266-1D9EE8DEA749

Q35060404-684572AC-AE58-4577-B1C0-043934A6AA81

Q35060404-8CB4E9BA-4559-45C3-9DC2-D9792EA8FF13

P2860

Q35060404-000A6560-3A10-475F-B3CE-3F625D927337

Q35060404-011455AE-C9A6-4DDA-85FF-D8FDFCA22108

Q35060404-075D991B-AF35-4D56-9B12-C22CEE491C49

Q35060404-0A061247-5BA3-4D65-B2FC-309CC69809FE

Q35060404-143B3133-C0D3-4837-A4E5-A2302FFB921A

Q35060404-1620D3F3-B0FD-470C-9ED6-B1711ED19167

Q35060404-1D5B28F7-63A1-46B1-B1BC-25F5614A169B

Q35060404-277DE47B-FD91-4905-A8D1-88C654AA811F

Q35060404-3ED42CC2-74CC-4550-95A6-C116F5F129A1

Q35060404-414A85CA-6837-409D-9DC8-F9EC3FAA83E5

P304

Q35060404-FBB33B13-2486-4A8F-A38F-9DD64F6B8C3D

P31

Q35060404-07B46CF2-3097-47CF-AD5F-C694B860056F

P356

Q35060404-4208FB2F-44C9-476B-B5CD-22B8EA1ED4B6

P407

Q35060404-54A1C963-0501-443C-BC52-EF7AB4B5BE0E

P433

Q35060404-8307FF85-1630-4C20-A5ED-FE5B913A8645

P478

Q35060404-A54C7291-D96C-460E-8C3C-BBEA3966D08E

P577

Q35060404-9A06F852-CC14-4FC9-9BB1-48FBAA38EBC5

P5875

Q35060404-BBA7FD80-9F69-447F-8FCE-A6DE3A509E02

P698

Q35060404-42CC136C-63A0-4C23-8967-60649F71A4FF

P932

Q35060404-16240F65-ACC9-467F-B5DD-70BDF9CE3203

P356

JOURNAL.PONE.0081006

P1433

P1476

The Ca²⁺-activated K⁺ channel ...... ion of allograft vasculopathy.

@en

P2093

Clare R Gregory

http://www.w3.org/2001/XMLSchema#string

Heike Wulff

http://www.w3.org/2001/XMLSchema#string

Jenny Lam

http://www.w3.org/2001/XMLSchema#string

Sonja Schrepfer

http://www.w3.org/2001/XMLSchema#string

Yi-Je Chen

http://www.w3.org/2001/XMLSchema#string

P2860

The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans

The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS

Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant

Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases

Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis

Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences

Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis

Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases

Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockers

Molecular cloning and characterization of the intermediate-conductance Ca(2+)-activated K(+) channel in vascular smooth muscle: relationship between K(Ca) channel diversity and smooth muscle cell function

P304

e81006

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0081006

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259208739

http://www.w3.org/2001/XMLSchema#string

P698

24312257

http://www.w3.org/2001/XMLSchema#string

P932

3843675

http://www.w3.org/2001/XMLSchema#string